MedTrace Logo

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

NCT05510908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 460

Last updated 2026-03-25

Study results available
· View outcomes & findings →

Summary

This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.

Conditions

  • HIV-Associated Malignant Neoplasm
  • HIV Infections
  • Cancer
  • AIDS Related Lymphoma
  • AIDS-related Kaposi Sarcoma
  • AIDS-Related Malignancy
  • Anal Cancer
  • HPV-Related Malignancy

Interventions

OTHER

Non-Interventional

Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.

OTHER

Non-Interventional Follow-up

Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • AIDS Malignancy Consortium

    lead NETWORK

Principal Investigators

  • Anna E Coghill, PhD, MPH · AIDS Malignancy Consortium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2025-02-28
Completion
2025-06-02

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05510908 on ClinicalTrials.gov